Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DB7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,750.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48,750.09 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This competitive, firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a single transaction against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from the contractor's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major healthcare solutions provider and pharmaceutical distributor.
This delivery order falls under AmerisourceBergen's existing $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, running through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. As a prime contractor with extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains, AmerisourceBergen provides brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract carries no set-aside designation, reflecting the company's competitiveness in open federal procurement for pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26F9DB7?
SPE2DR26F9DB7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9DB7 worth?
The government has obligated $48,750 on SPE2DR26F9DB7.
Is contract SPE2DR26F9DB7 an order under another contract?
Yes. SPE2DR26F9DB7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DB7 competed?
The extent of competition for SPE2DR26F9DB7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award